Package 71335-1296-1

{"route": ["SUBLINGUAL"], "spl_id": "9edc1edc-dc15-456c-b48f-aebe63540b31", "openfda": {"nui": ["N0000175689", "N0000175685", "N0000175691", "N0000000154"], "unii": ["40D3SCR4GZ", "36B82AMQ7N"], "rxcui": ["351266"], "spl_set_id": ["fc2755a5-3292-4b49-872d-e22c386a4e44"], "pharm_class_epc": ["Partial Opioid Agonist [EPC]", "Opioid Antagonist [EPC]"], "pharm_class_moa": ["Partial Opioid Agonists [MoA]", "Opioid Antagonists [MoA]"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (71335-1296-1)", "package_ndc": "71335-1296-1", "marketing_start_date": "20190812"}, {"sample": false, "description": "10 TABLET in 1 BOTTLE (71335-1296-2)", "package_ndc": "71335-1296-2", "marketing_start_date": "20240517"}], "brand_name": "Buprenorphine and Naloxone", "product_id": "71335-1296_9edc1edc-dc15-456c-b48f-aebe63540b31", "dosage_form": "TABLET", "pharm_class": ["Opioid Antagonist [EPC]", "Opioid Antagonists [MoA]", "Partial Opioid Agonist [EPC]", "Partial Opioid Agonists [MoA]"], "product_ndc": "71335-1296", "dea_schedule": "CIII", "generic_name": "Buprenorphine and Naloxone", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Buprenorphine and Naloxone", "active_ingredients": [{"name": "BUPRENORPHINE", "strength": "2 mg/1"}, {"name": "NALOXONE", "strength": ".5 mg/1"}], "application_number": "ANDA205022", "marketing_category": "ANDA", "marketing_start_date": "20160919", "listing_expiration_date": "20261231"}